How much profit has Byhealth Co made this year?
Byhealth Co has made 926.73 M CNY this year.
Byhealth Co Net Income 2024
Byhealth Co Net Income
926.73 M CNY
Ticker
300146.SZ
ISIN
CNE100000Y84
In 2024, Byhealth Co's profit amounted to 926.73 M CNY, a -46.93% increase from the 1.75 B CNY profit recorded in the previous year.
The Byhealth Co Net Income history
| YEAR | NET INCOME (undefined CNY) |
|---|---|
| 2026e | 1.27 |
| 2025e | 1.09 |
| 2024e | 0.93 |
| 2023 | 1.75 |
| 2022 | 1.39 |
| 2021 | 1.75 |
| 2020 | 1.52 |
| 2019 | -0.36 |
| 2018 | 1 |
| 2017 | 0.76 |
| 2016 | 0.54 |
| 2015 | 0.64 |
| 2014 | 0.5 |
| 2013 | 0.42 |
| 2012 | 0.28 |
| 2011 | 0.19 |
| 2010 | 0.09 |
| 2009 | 0.05 |
| 2008 | 0.03 |
| 2007 | 0.01 |
Byhealth Co Revenue, EBIT, Net Income CNE100000Y84 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Byhealth Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Byhealth Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Byhealth Co’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Byhealth Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Byhealth Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Byhealth Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Byhealth Co’s growth potential.
Byhealth Co Revenue, EBIT and net profit per share
| Date | Byhealth Co Revenue | Byhealth Co EBIT | Byhealth Co Net Income |
|---|---|---|---|
| 2026e | 10.3 B CNY | 2.66 B CNY | 1.27 B CNY |
| 2025e | 9.37 B CNY | 2.4 B CNY | 1.09 B CNY |
| 2024e | 8.59 B CNY | 2.09 B CNY | 926.73 M CNY |
| 2023 | 9.41 B CNY | 1.98 B CNY | 1.75 B CNY |
| 2022 | 7.86 B CNY | 1.66 B CNY | 1.39 B CNY |
| 2021 | 7.43 B CNY | 1.89 B CNY | 1.75 B CNY |
| 2020 | 6.09 B CNY | 1.4 B CNY | 1.52 B CNY |
| 2019 | 5.26 B CNY | 1.2 B CNY | -358.4 M CNY |
| 2018 | 4.35 B CNY | 1.09 B CNY | 999.3 M CNY |
| 2017 | 3.11 B CNY | 759 M CNY | 762.8 M CNY |
| 2016 | 2.31 B CNY | 557.1 M CNY | 535.2 M CNY |
| 2015 | 2.27 B CNY | 637.5 M CNY | 635.5 M CNY |
| 2014 | 1.71 B CNY | 510.4 M CNY | 502.6 M CNY |
| 2013 | 1.48 B CNY | 468.6 M CNY | 421.7 M CNY |
| 2012 | 1.07 B CNY | 295.6 M CNY | 280.4 M CNY |
| 2011 | 658 M CNY | 182.2 M CNY | 186.4 M CNY |
| 2010 | 346.1 M CNY | 106.3 M CNY | 92.1 M CNY |
| 2009 | 205.3 M CNY | 61.6 M CNY | 52.2 M CNY |
| 2008 | 141.9 M CNY | 36.3 M CNY | 26.7 M CNY |
| 2007 | 66.9 M CNY | 17.2 M CNY | 12.1 M CNY |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2007 | 66.9 M CNY | 17.2 M CNY | 12.1 M CNY |
| 2008 | 141.9 M CNY | 36.3 M CNY | 26.7 M CNY |
| 2009 | 205.3 M CNY | 61.6 M CNY | 52.2 M CNY |
| 2010 | 346.1 M CNY | 106.3 M CNY | 92.1 M CNY |
| 2011 | 658 M CNY | 182.2 M CNY | 186.4 M CNY |
| 2012 | 1.07 B CNY | 295.6 M CNY | 280.4 M CNY |
| 2013 | 1.48 B CNY | 468.6 M CNY | 421.7 M CNY |
| 2014 | 1.71 B CNY | 510.4 M CNY | 502.6 M CNY |
| 2015 | 2.27 B CNY | 637.5 M CNY | 635.5 M CNY |
| 2016 | 2.31 B CNY | 557.1 M CNY | 535.2 M CNY |
| 2017 | 3.11 B CNY | 759 M CNY | 762.8 M CNY |
| 2018 | 4.35 B CNY | 1.09 B CNY | 999.3 M CNY |
| 2019 | 5.26 B CNY | 1.2 B CNY | -358.4 M CNY |
| 2020 | 6.09 B CNY | 1.4 B CNY | 1.52 B CNY |
| 2021 | 7.43 B CNY | 1.89 B CNY | 1.75 B CNY |
| 2022 | 7.86 B CNY | 1.66 B CNY | 1.39 B CNY |
| 2023 | 9.41 B CNY | 1.98 B CNY | 1.75 B CNY |
| 2024e | 8.59 B CNY | 2.09 B CNY | 926.73 M CNY |
| 2025e | 9.37 B CNY | 2.4 B CNY | 1.09 B CNY |
| 2026e | 10.3 B CNY | 2.66 B CNY | 1.27 B CNY |
Byhealth Co stock margins CNE100000Y84 ·
The Byhealth Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Byhealth Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Byhealth Co.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Byhealth Co's sales revenue. A higher gross margin percentage indicates that the Byhealth Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Byhealth Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Byhealth Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Byhealth Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Byhealth Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Byhealth Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Byhealth Co Margin History
| Byhealth Co Gross margin | Byhealth Co Profit margin | Byhealth Co EBIT margin | Byhealth Co Profit margin |
|---|---|---|---|
| 2026e | 68.76 % | 25.83 % | 12.34 % |
| 2025e | 68.76 % | 25.58 % | 11.68 % |
| 2024e | 68.76 % | 24.38 % | 10.79 % |
| 2023 | 68.76 % | 21.03 % | 18.56 % |
| 2022 | 68.12 % | 21.11 % | 17.63 % |
| 2021 | 65.81 % | 25.38 % | 23.6 % |
| 2020 | 62.67 % | 22.96 % | 25.01 % |
| 2019 | 65.37 % | 22.81 % | -6.81 % |
| 2018 | 67.18 % | 25.14 % | 22.97 % |
| 2017 | 66.94 % | 24.4 % | 24.52 % |
| 2016 | 64.11 % | 24.13 % | 23.18 % |
| 2015 | 66.17 % | 28.13 % | 28.05 % |
| 2014 | 64.9 % | 29.94 % | 29.48 % |
| 2013 | 64.65 % | 31.62 % | 28.45 % |
| 2012 | 63.3 % | 27.71 % | 26.29 % |
| 2011 | 63.02 % | 27.69 % | 28.33 % |
| 2010 | 63.51 % | 30.71 % | 26.61 % |
| 2009 | 62.2 % | 30 % | 25.43 % |
| 2008 | 59.41 % | 25.58 % | 18.82 % |
| 2007 | 53.81 % | 25.71 % | 18.09 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2007 | 53.81 % | 25.71 % | 18.09 % |
| 2008 | 59.41 % | 25.58 % | 18.82 % |
| 2009 | 62.2 % | 30 % | 25.43 % |
| 2010 | 63.51 % | 30.71 % | 26.61 % |
| 2011 | 63.02 % | 27.69 % | 28.33 % |
| 2012 | 63.3 % | 27.71 % | 26.29 % |
| 2013 | 64.65 % | 31.62 % | 28.45 % |
| 2014 | 64.9 % | 29.94 % | 29.48 % |
| 2015 | 66.17 % | 28.13 % | 28.05 % |
| 2016 | 64.11 % | 24.13 % | 23.18 % |
| 2017 | 66.94 % | 24.4 % | 24.52 % |
| 2018 | 67.18 % | 25.14 % | 22.97 % |
| 2019 | 65.37 % | 22.81 % | -6.81 % |
| 2020 | 62.67 % | 22.96 % | 25.01 % |
| 2021 | 65.81 % | 25.38 % | 23.6 % |
| 2022 | 68.12 % | 21.11 % | 17.63 % |
| 2023 | 68.76 % | 21.03 % | 18.56 % |
| 2024e | 68.76 % | 24.38 % | 10.79 % |
| 2025e | 68.76 % | 25.58 % | 11.68 % |
| 2026e | 68.76 % | 25.83 % | 12.34 % |
Byhealth Co Aktienanalyse
What does Byhealth Co do?
Byhealth Co Ltd is a company that specializes in the manufacture and sale of dietary supplements and health products. The company was founded in 1998 in Guangzhou, China. The founder of Byhealth, Mr. Liang Guangwei, has early on specialized in the production of high-quality health products and cosmetics. As a result, Byhealth quickly became a leading company in the dietary supplement industry. The company enjoys a very good reputation, particularly in Asia, and has received multiple awards. The goal of Byhealth is to offer high-quality dietary supplements and health products that support the health and well-being of customers. The company relies on its own research and development, which guarantees a high quality of the products. Byhealth distributes its products worldwide, particularly in Asia, Europe, and North America. The company works closely with distribution partners to reach a wide customer base. To achieve this, Byhealth has developed a variety of product lines tailored to different customer needs. These include products to support the immune system, digestion, sleep, skin, metabolism, and weight loss. Byhealth pays special attention to its product line Revotropix, which is among the most well-known and popular in the industry. The products contain a variety of plant-based and natural ingredients that are supposed to alleviate symptoms of stress, pain, and depression. The products are available in various forms, such as capsules or powder. Another important area is weight loss products, which are intended to help customers control and reduce their weight. These include fat-binding tablets and products that stimulate metabolism. Byhealth strictly adheres to the highest quality standards in the production of its products. All products are produced in accordance with Good Manufacturing Practice (GMP) and other international standards. The company uses only natural ingredients to ensure that all products are safe and effective. As an innovative company, Byhealth also relies on new technologies and trends to further improve its products. For example, the company uses the latest technology for the extraction of natural ingredients to ensure a higher efficacy and purity of its products. Overall, Byhealth has earned an excellent reputation in the industry with its high-quality dietary supplements and health products. Through its research and development and the use of state-of-the-art production methods, Byhealth is able to offer a wide range of health products that help customers improve their health and well-being. Byhealth Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Byhealth Co's Profit Margins
The profit margins of Byhealth Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Byhealth Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Byhealth Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Byhealth Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Byhealth Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Byhealth Co stock
How has the profit developed compared to last year?
The profit has increased by -46.93% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Byhealth Co publish its earnings?
Byhealth Co publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Byhealth Co?
The profits of Byhealth Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Byhealth Co?
You can learn more about the earnings of Byhealth Co by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Byhealth Co pay?
Over the past 12 months, Byhealth Co paid a dividend of 0.18 CNY . This corresponds to a dividend yield of about 1.21 %. For the coming 12 months, Byhealth Co is expected to pay a dividend of 0.19 CNY.
What is the dividend yield of Byhealth Co?
The current dividend yield of Byhealth Co is 1.21 %.
When does Byhealth Co pay dividends?
Byhealth Co pays a quarterly dividend. This is distributed in the months of May, May, May, May.
How secure is the dividend of Byhealth Co?
Byhealth Co paid dividends every year for the past 16 years.
What is the dividend of Byhealth Co?
For the upcoming 12 months, dividends amounting to 0.19 CNY are expected. This corresponds to a dividend yield of 1.25 %.
In which sector is Byhealth Co located?
Byhealth Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Byhealth Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Byhealth Co from 4/22/2024 amounting to 0.9 CNY, you needed to have the stock in your portfolio before the ex-date on 4/22/2024.
When did Byhealth Co pay the last dividend?
The last dividend was paid out on 4/22/2024.
What was the dividend of Byhealth Co in the year 2023?
In the year 2023, Byhealth Co distributed 0.7 CNY as dividends.
In which currency does Byhealth Co pay out the dividend?
The dividends of Byhealth Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Byhealth Co
Our stock analysis for Byhealth Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Byhealth Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.